跳至主要内容
临床试验/JPRN-UMIN000051618
JPRN-UMIN000051618已完成4 期

Causal risk estimation of fluoroquinolones for the occurrence of aortic events using claims database - Risk assessment of fluoroquinolones for the occurrence of aortic events

Shizuoka Graduate University of Public Health0 个研究点目标入组 155,126 人开始时间: 2023年7月15日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
155,126

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
50years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • -Patients who received a prescription for fluoroquinolones or amoxicillin (+/- clavulanic acid) in the 4 months prior to the start of observation (antibiotic prescription episode) -Patients who were hospitalized in the 12 months prior to the start of observation -Cases with history of aortic aneurysm or aortic dissection up to prescription of oral antibiotic (these cases will be analyzed as an additional analysis) -Cases with Marfan syndrome, vascular type Ehlers-Danlos syndrome, and Lois-Dietz syndrome up to prescription of oral antibiotic -Cases that do not allow for a baseline period of 12 months prior to the start of observation

研究者

相似试验